Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10506 in Chinese Adult Patients With Insomnia Disorder
NCT07587385Phase 3Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- May 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of HS-10506 in insomnia disorder, sponsored by Hansoh Pharmaceutical Group. Planned start May 2026; status: not yet recruiting.
02
Drugs
HS-10506
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT07587385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587385.